The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS. Medicare beneficiaries have two options for ...
In anticipation of the CY2027 bid deadline, CMS released both the CY2027 final rule for Medicare Advantage (“MA”) and Medicare Part D (the “Final Rule”) as well as the CY2027 MA Capitation Rates and ...
Medicare Part D premiums will increase next year, the Centers for Medicare & Medicaid Services (CMS) announced as the agency adjusts a Biden-era program. The base premium will be $38.99, up from ...
Forbes contributors publish independent expert analyses and insights. Bob Carlson researches all facets of retirement finances. The final numbers aren’t in yet, but it looks like premiums for Medicare ...
The final rule, issued on April 2, puts forth policy and technical changes to the MA and Part D programs for 2027 and beyond. Health Equity Index: In last fall’s proposed rule for MA and Part D, CMS ...
On January 1, there will be some changes consumers should note for Medicare, a federal health insurance program for adults ages 65 and older in the United States. Every year, older adults have between ...
Hosted on MSN
CMS Rejects Select Medicare Drug Plan Bids, Tightens Oversight to Curb Premium Hikes for 2026
WASHINGTON, D.C. — In a rare and assertive regulatory move, the Centers for Medicare & Medicaid Services (CMS) has exercised its statutory authority to reject certain standalone prescription drug plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results